
NSF appoints senior director
pharmafile | September 6, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing |Â Â NSF, ToscanoÂ
Public health organisation NSF International has appointed George Toscano as senior director of Quality Systems, Pharmaceuticals, Biotech and Biologics.
Toscano has more than 16 years of experience helping companies in the global pharmaceutical, biologic and biotech markets develop and execute quality systems solutions.
As senior director at NSF he will assist companies in the pharma, biologic and biotech industries, both foreign and domestic, in developing compliant quality and regulatory strategies.
His primary area of focus includes NDA (new drug application) and ANDA (abbreviated new drug application) review sections covering production and batch records, stability data, validation data, qualification records, supplements, amendments, and bio-equivalence studies.
He will report to Maxine Fritz, executive VP of Pharmaceuticals and Biologics at Becker & Associates Consulting, part of NSF International’s Health Sciences Division.
“George’s extensive experience in quality systems will play an integral role in assisting companies to develop and implement quality solutions that will help expand their operations while safeguarding their reputation,” said Bob Pietrowski, VP of Health Sciences for NSF International.






